Not a first-line test for Lyme disease. May be useful if strong suspicion of Lyme disease persists in spite of persistent negative serologic testing. Blood and CSF specimens have poor clinical sensitivity for detection of Borrelia burgdorferi by PCR.
Qualitative Polymerase Chain Reaction
Mon, Wed, Fri
New York DOH Approval Status
Lavender (EDTA), pink (K2EDTA) or serum separator tube. OR CSF, synovial fluid or tissue.
Separate serum or plasma from cells. Transfer 1 mL serum, plasma, CSF or synovial fluid to a sterile container. (Min: 0.5 mL). Tissue: Transfer to a sterile container and freeze immediately.
Heparinized specimens, tissues in optimal cutting temperature compound.
Specimen source required.
Tissue: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 1 year
All Others: Ambient: 8 hours; Refrigerated: 72 hours; Frozen: 1 year
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|0051048||Borrelia Species Source||31208-2|
|0055570||Borrelia Species DNA Detection by PCR||4991-6|
- B. burgdorferi DNA detection
- Borrelia burgdorferi
- Lyme Disease
- Lyme Disease PCR
- Tick Borne Disease